A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment

Xun Yuan,1,* Wenxiang Ji,2,* Si Chen,1 Yuling Bao,3 Songwei Tan,3 Shun Lu,2 Kongming Wu,1 Qian Chu11Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 2Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Ton...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuan X, Ji W, Chen S, Bao Y, Tan S, Lu S, Wu K, Chu Q
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/9dc69c63c0d64c32967bc6c9d3a9965c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9dc69c63c0d64c32967bc6c9d3a9965c
record_format dspace
spelling oai:doaj.org-article:9dc69c63c0d64c32967bc6c9d3a9965c2021-12-02T06:37:58ZA novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment1178-2013https://doaj.org/article/9dc69c63c0d64c32967bc6c9d3a9965c2016-05-01T00:00:00Zhttps://www.dovepress.com/a-novel-paclitaxel-loaded-polydl-lactide-co-glycolide-tween-80-copolym-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xun Yuan,1,* Wenxiang Ji,2,* Si Chen,1 Yuling Bao,3 Songwei Tan,3 Shun Lu,2 Kongming Wu,1 Qian Chu11Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 2Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 3School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China*These authors contributed equally to this workAbstract: Drug resistance has become a main obstacle for the effective treatment of lung cancer. To address this problem, a novel biocompatible nanoscale package, poly(D,L-lactide-co-glycolide)-Tween 80, was designed and synthesized to overcome paclitaxel (PTX) resistance in a PTX-resistant human lung cancer cell line. The poly(D,L-lactide-co-glycolide) (PLGA)-Tween 80 nanoparticles (NPs) could efficiently load PTX and release the drug gradually. There was an increased level of uptake of PLGA-Tween 80 in PTX-resistant lung cancer cell line A549/T, which achieved a significantly higher level of cytotoxicity than both PLGA NP formulation and Taxol®. The in vivo antitumor efficacy also showed that PLGA-Tween 80 NP was more effective than Taxol®, indicating that PLGA-Tween 80 copolymer was a promising carrier for PTX in resistant lung cancer. Keywords: poly(D,L-lactide-co-glycolide), Tween 80, nanoparticle, drug resistance, lung cancerYuan XJi WChen SBao YTan SLu SWu KChu QDove Medical Pressarticlepoly(DL-lactide-co-glycolide)Tween 80nanoparticledrug resistancelung cancerMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2016, Iss default, Pp 2119-2131 (2016)
institution DOAJ
collection DOAJ
language EN
topic poly(D
L-lactide-co-glycolide)
Tween 80
nanoparticle
drug resistance
lung cancer
Medicine (General)
R5-920
spellingShingle poly(D
L-lactide-co-glycolide)
Tween 80
nanoparticle
drug resistance
lung cancer
Medicine (General)
R5-920
Yuan X
Ji W
Chen S
Bao Y
Tan S
Lu S
Wu K
Chu Q
A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
description Xun Yuan,1,* Wenxiang Ji,2,* Si Chen,1 Yuling Bao,3 Songwei Tan,3 Shun Lu,2 Kongming Wu,1 Qian Chu11Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 2Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 3School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China*These authors contributed equally to this workAbstract: Drug resistance has become a main obstacle for the effective treatment of lung cancer. To address this problem, a novel biocompatible nanoscale package, poly(D,L-lactide-co-glycolide)-Tween 80, was designed and synthesized to overcome paclitaxel (PTX) resistance in a PTX-resistant human lung cancer cell line. The poly(D,L-lactide-co-glycolide) (PLGA)-Tween 80 nanoparticles (NPs) could efficiently load PTX and release the drug gradually. There was an increased level of uptake of PLGA-Tween 80 in PTX-resistant lung cancer cell line A549/T, which achieved a significantly higher level of cytotoxicity than both PLGA NP formulation and Taxol®. The in vivo antitumor efficacy also showed that PLGA-Tween 80 NP was more effective than Taxol®, indicating that PLGA-Tween 80 copolymer was a promising carrier for PTX in resistant lung cancer. Keywords: poly(D,L-lactide-co-glycolide), Tween 80, nanoparticle, drug resistance, lung cancer
format article
author Yuan X
Ji W
Chen S
Bao Y
Tan S
Lu S
Wu K
Chu Q
author_facet Yuan X
Ji W
Chen S
Bao Y
Tan S
Lu S
Wu K
Chu Q
author_sort Yuan X
title A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
title_short A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
title_full A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
title_fullStr A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
title_full_unstemmed A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
title_sort novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/9dc69c63c0d64c32967bc6c9d3a9965c
work_keys_str_mv AT yuanx anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT jiw anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT chens anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT baoy anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT tans anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT lus anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT wuk anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT chuq anovelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT yuanx novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT jiw novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT chens novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT baoy novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT tans novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT lus novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT wuk novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
AT chuq novelpaclitaxelloadedpolydllactidecoglycolidetween80copolymernanoparticleovercomingmultidrugresistanceforlungcancertreatment
_version_ 1718399829153939456